Expanded Xofluza approval includes seniors at risk of flu complications
By
Alicia Lasek
Oct 20, 2019
The U.S. Food & Drug Administration has expanded approval of the oral antiviral drug Xofluza for people at high risk of flu complications.
Also in the News for Monday, Feb. 12
Feb 12, 2018
New flu treatments may be here in time for next flu season … Maryland representative pushes bill for bed rails in nursing homes, despite federal regulations against them … Simple physical performance...